ALX Oncology increases inducement plan share reserve by 1.3M shares to total 2.8M shares

ALX ONCOLOGY HOLDINGS INC

Board amended 2025 Inducement Equity Incentive Plan to reserve an additional 1,300,000 shares of common stock.
Total shares reserved under the inducement plan now 2,800,000.
Amendment adopted without stockholder approval per Nasdaq inducement award exception rules.
Awards under the plan will be granted only to new employees as material inducement to join the Company.
Plan terms are substantially similar to the Amended and Restated 2020 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.